• Skip to main content

DistilINFO LifeSciences

Weekly round up from Life Sciences Industry.

  • Publications
    • Home
    • DistilINFO HealthPlan
    • DistilINFO HospitalIT
    • DistilINFO IT
    • DistilINFO Retail
    • DistilINFO POPHealth
    • DistilINFO Ageing
    • DistilINFO Life Sciences
    • DistilINFO GovHealth
    • DistilINFO EHS
    • DistilINFO HealthIndia
    • Subscribe
    • Submit Article
    • Advertise
    • Newsletters

AI tool matches cancer patients with relevant clinical trials

Share:

March 12, 2019

A 14-week health technology “sprint” sponsored by the U.S. Census Bureau and coordinated by the HHS has produced an AI tool that developers claim could revolutionize the way researchers match cancer patients with clinical trials.

The tool, a novel knowledge graph created by a team at the Department of Energy’s Oak Ridge National Laboratory Health Data Sciences Institute, was developed as part of The Opportunity Project Health Sprint, according to a release. Oak Ridge’s team was just 1 of 10 to develop a digital tool to address challenges relevant to medical conditions like cancer or Lyme disease.

Spearheaded by project lead Ioana Danciu, the scientists applied unsupervised machine learning and large-scale graph analytic methodologies to open datasets provided by governmental agencies like the National Cancer Institute and Department of Veterans Affairs. Danciu and her colleagues added clinical trial data to an exoscale knowledge graph that continuously collects and connects data across sources like EHRs and medical ontologies.

“One of the major obstacles facing cancer trial eligibility is the unstructured nature of the data,” Danciu said in the release. “Artificial intelligence and natural language processing tools refine and advance the process of matching cancer patients to promising clinical trials.”

Want to publish your own articles on DistilINFO Publications?

Send us an email, we will get in touch with you.

Using AI approaches similar to what Netflix uses to tailor its movie suggestions, the team was able to present information in a much clearer, more meaningful way.

According to the release, the TOP project built upon existing AI research at the Oak Ridge lab, which so far has been used to extract information with signals from low signal-to-noise ratios, developed algorithms capable of accelerating modeling and simulation with little training data and designed novel biomimetic neuromorphic devices capable of detecting epileptic seizures.

“This was an exploratory project,” Danciu said. “Ultimately, we are interested in unleashing the power of the unique computing resources and data science expertise available at ORNL to find end-to-end solutions to big problems with broad societal impact, and clinical trial patient matching certainly fits that description.”

Date: March 13, 2019

Source: AI in Healthcare

Coffee with DistilINFO's Morning Updates...

Sign up for DistilINFO e-Newsletters.

Just a little bit more about you...
PROCEED
Choose Lists
BACK

Related Stories

  • Apple Pulls 181 Vaping-related Apps from Store Worldwide, Cites Health IssuesApple Pulls 181 Vaping-related Apps from Store Worldwide, Cites Health Issues
  • ATENTIV, Children’s  Specialized Hospital Look To Infuse Digital Behavioral Therapy Into Primary CareATENTIV, Children’s Specialized Hospital Look To Infuse Digital Behavioral Therapy Into Primary Care
  • In-Depth: Technology’s role in tackling the global mental health crisisIn-Depth: Technology’s role in tackling the global mental health crisis
  • Haves vs. Have-Nots in Healthcare: Why The Haves Are Still WinningHaves vs. Have-Nots in Healthcare: Why The Haves Are Still Winning
  • Somatus Scoops Up $64M Series C FundingSomatus Scoops Up $64M Series C Funding
  • Mammoth Lands 2 Major Partnerships to Use CRISPR to Solve COVID19 Testing Shortage, At ScaleMammoth Lands 2 Major Partnerships to Use CRISPR to Solve COVID19 Testing Shortage, At Scale
  • GI Partners and TA Associates to Acquire Allscripts’ stake in Netsmart TechnologiesGI Partners and TA Associates to Acquire Allscripts’ stake in Netsmart Technologies
  • Google to Acquire Fitbit for $2.1B in Cash, Will Not Use Fitbit Data for Google AdsGoogle to Acquire Fitbit for $2.1B in Cash, Will Not Use Fitbit Data for Google Ads

Trending This Week

  • Pharmaceutical Compliance Software Market 2022 to Showing Impressive Growth By | [no. of Pages: 118] Industry Trends, Share, Size, Top Key Players Analysis and Forecast Research, Shares and Strategies | By Proficient Market Insights
  • Biosimilars Market: Rise in Number of Cancer Patients to Boost Market
  • Biotechnology and Pharmaceutical Services Outsourcing Market Size 2022 Analysis Report By Competitive Vendors in Top Regions and Countries, Production Types, Applications, Growth, Current Trends and Forecast to 2026
  • The Global Wearable Injectors Market Size is Expected to Reach $12.9 Billion By 2028, Rising at a Market Growth of 9.2% CAGR During the Forecast Period
  • Treprostinil Drugs Market – Insights on how Players Have Cemented Their Positions with Disruptive Technologies, Key Players are United Therapeutics, Novartis, and Teva Pharmaceutical Industries Ltd
  • Protect Pharmaceutical Corporation has Acquired Top Notch Software Development Company

About Us

DistilINFO is media company that publishes Industry news, views and Interviews. We distil the information for you – saving time and keeping you up to date on your interest areas.

More About Us

Follow Us


Useful Links

  • Subscribe
  • Contact
  • Advertise
  • Privacy Policy
  • Terms of Service
  • Feedback

All Publications

  • DistilINFO HealthPlan Advisory
  • DistilINFO HospitalIT Advisory
  • DistilINFO IT Advisory
  • DistilINFO Retail Advisory
  • DistilINFO POPHealth Advisory
  • DistilINFO Ageing Advisory
  • DistilINFO Life Sciences Advisory
  • DistilINFO GovHealth Advisory
  • DistilINFO EHS Advisory
  • DistilINFO HealthIndia Advisory

© DistilINFO Publications